Xcout Intel
Tacalyx competitors & alternatives
The 12 closest competitors and alternatives to Tacalyx among drug discovery companies — ranked by similarity to what Tacalyx actually does, not by market-cap band.
Subscribe to see Tacalyx’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Tacalyx
Tacalyx is a life sciences and biotechnology company headquartered in Berlin, Germany, focused on developing lead TACA-targeted therapeutics.
Tacalyx at a glance
Tacalyx is a drug discovery company headquartered in Germany. It has raised at least $22.7M across the 2 funding rounds on record. Its most recent funding round, Seed, raised $15M in June 2024. Xcout tracks 11 named people at Tacalyx, including Jean Engela (CEO).
Tacalyx leadership
- Jean EngelaCEO
- Dr. Klaus SchollmeierChairman of the Board
- Peter SondermannCSO & Co-founder
- Detlev MennerichBoehringer Ingelheim Venture Fund (BIVF)
- Dr. Frank HenselHigh-Tech Gründerfonds
- Dr. Peter NeubeckKurma Partners
5 more named people on record for Tacalyx, with roles, board committees and tenure — see the full roster →
Tacalyx funding rounds
At least $22.7M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $15M | 4 named | |
| Seed | $7.7M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Tacalyx competitors
Ranked by semantic similarity — how close each company is to Tacalyx by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
Ariceum Therapeutics is a radiopharmaceutical company headquartered in Berlin, Germany, with operations across several countries, focused on the development of novel medical treatments.
Similar drug discovery company
Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Boston, Massachusetts. The company discovers and develops Anticalin-based drugs designed to address significant medical needs.
Similar drug discovery company
Smartbax is a biotechnology startup founded in Munich, Germany, in 2021, dedicated to developing innovative next-generation antibiotics to combat the rising threat of multidrug-resistant bacteria.
Similar drug discovery company
Versameb AG is a privately held biopharmaceutical company focused on discovering and developing innovative RNA-based therapeutics.
Similar drug discovery company
Kupando is a pioneering Berlin-based biopharmaceutical and biotech company headquartered in Schönefeld, Germany. The company is focused on the research and clinical development of innovative treatments to fight cancer and infectious diseases.
Similar drug discovery company
Peptomyc is a clinical-stage biotechnology company headquartered in Barcelona, Spain, specializing in the development of protein and peptide therapeutics for cancer.
Similar drug discovery company
MinervaX is a privately held biotechnology company headquartered in Copenhagen, Denmark, pursuing the development of a novel maternal prophylactic vaccine for the prevention of Group B Streptococcus disease.
Similar drug discovery company
AnaCardio AB is a privately held Swedish clinical-stage biopharmaceutical company headquartered in Stockholm. The company focuses on developing novel drugs designed to treat heart failure.
Similar drug discovery company
OncoMyx Therapeutics, Inc. is a biotechnology company headquartered in Phoenix, Arizona, that develops innovative oncolytic immunotherapies to target and destroy tumors.
Similar drug discovery company
Cyllene Therapeutics is a global leader in non-replicating HSV-1 therapeutics headquartered in Paris, France, with additional presence in New York, USA.
Similar drug discovery company
ApoGlyx is a Swedish life science company located in Lund that focuses on developing innovative medicines for acute systemic inflammatory diseases such as sepsis and acute pancreatitis.
Similar drug discovery company
Vivacta Biotechnology is a biopharmaceutical company headquartered in Shanghai, China, specializing in innovative biotechnology research. The company is focused on developing in vivo CAR-T therapies utilizing a targeted delivery system.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Tacalyx and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Tacalyxand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →